Efficacy of soothing cream gel in the range of motion and chronic pain at the shoulder and elbow: protocol of a double-blinded, randomised, placebo-controlled trial

被引:0
|
作者
Lo, Cho Wing [1 ,2 ]
Sum, Kim Wai Raymond [3 ]
Leung, Fung Lin Elean [4 ]
Yang, Yijian [3 ]
Chan, Kam Leung [2 ]
Lam, Koon Kit [1 ,2 ]
Lau, Kam Wai [1 ,2 ]
Sum, Chi Him [1 ,2 ]
Lin, Wai Ling [2 ]
Ho, Shing Hin [2 ]
Lin, Zhi-Xiu [2 ]
机构
[1] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Sch Chinese Med, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Sports Sci & Phys Educ, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Phys Educ Unit, Hong Kong, Peoples R China
来源
BMJ OPEN | 2024年 / 14卷 / 07期
关键词
pain management; chronic pain; clinical trial; complementary medicine; elbow & shoulder; sports medicine; QUALITY-OF-LIFE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OSTEOARTHRITIS EVIDENCE; MUSCULOSKELETAL PAIN; HEALTH SURVEY; UPPER-LIMB; RELIABILITY; SAFETY; METAANALYSIS; DISORDERS;
D O I
10.1136/bmjopen-2024-085856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Upper limb problems have a significant impact on the global population leading to pain and restricted joint mobility, ultimately impacting their quality of life. Traditional treatments, such as non-steroidal anti-inflammatory drugs and corticosteroids, often come with undesirable side effects, prompting patients to seek alternative therapies. In this trial, we hypothesise that soothing cream gel (SCG) will improve range of motion and chronic pain in the shoulder and elbow. The objective of this trial is to evaluate the efficacy of SCG in improving the range of motion and chronic pain in the shoulder and elbow. Methods and analysis A double-blinded, randomised, placebo-controlled trial is conducted to compare the effects of SCG and placebo gel. SCG contains Vitis vinifera essence, Melaleuca viridiflora essential oil, etc, and is manufactured according to Good Manufacturing Practice standards. The placebo gel will be processed with similar appearance, texture and scent but will lack active ingredients. 70 participants with upper limb problems will be recruited from four study sites, including clinical centres and a sport department at the Chinese University of Hong Kong (CUHK). Participants will be randomly assigned to either treatment group or placebo group for 2 weeks. Primary outcome will be the range of motion in the upper limb, assessed by a goniometer, to measure active flexion and abduction for the shoulder, and active flexion and extension for the elbow. The primary efficacy analyses will be based on the full analysis set following the intention-to-treat principle. Ethics and dissemination The trial has obtained approval from the joint CUHK-New Territories East Cluster (CRE-2023.142), and the patient enrolment commenced in July 2023. Written informed consent will be obtained from all participants prior to participation. Study results will be disseminated through publication in peer-reviewed journals and presentations at conference.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Estimation of treatment allocation in a randomised, double-blinded, placebo-controlled trial
    Milica, Popovic
    Nicole, Cesana-Nigro
    Bettina, Winzeler
    Robert, Thomann
    Philipp, Schutz
    Beat, Mueller
    Mirjam, Christ-Crain
    Claudine, Blum A.
    SWISS MEDICAL WEEKLY, 2019, 149
  • [2] Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial)
    Juel, Jacob
    Olesen, Soren Schou
    Olesen, Anne Estrup
    Poulsen, Jakob Lykke
    Dahan, Albert
    Wilder-Smith, Oliver
    Madzak, Adnan
    Frokjaer, Jens Brondum
    Drewes, Asbjorn Mohr
    BMJ OPEN, 2015, 5 (03):
  • [3] Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial
    Licina, Ana
    Russell, Jeremy
    Silvers, Andrew
    Jin, Xin
    Denny, Jason
    BMJ OPEN, 2019, 9 (08):
  • [4] Randomised, placebo-controlled, double-blinded trial of fecal microbiota transplantation in severe obesity: a study protocol
    Hanssen, Hege Marie
    Fjellstad, Maria Serafia
    Skjevling, Linn
    Johnsen, Peter Holger
    Kulseng, Bard
    Goll, Rasmus
    Alma, Kristin Helen
    Valle, Per-Christian
    BMJ OPEN, 2023, 13 (12):
  • [5] EVALUATION OF EFFECTIVENESS OF LASER ACUPUNCTURE ON OSTEOARTHRITIS KNEE PAIN - RANDOMISED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
    Rees, Meikin
    Meier, Peter
    Brown, James
    LASERS IN SURGERY AND MEDICINE, 2017, 49 : 45 - 45
  • [6] Evaluating efficacy of a chitosan product using a double-blinded, placebo-controlled protocol
    Kaats, Gilbert R.
    Michalek, Joel E.
    Preuss, Harry G.
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2006, 25 (05) : 389 - 394
  • [7] The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial
    Ali Movahed
    Afshin Ostovar
    Daryoush Iranpour
    Sijo Joseph Thandapilly
    Pema Raj
    Xavier Lieben Louis
    James Michael Smoliga
    Thomas Netticadan
    Trials, 17
  • [8] The efficacy of resveratrol in controlling hypertension: study protocol for a randomized, crossover, double-blinded, placebo-controlled trial
    Movahed, Ali
    Ostovar, Afshin
    Iranpour, Daryoush
    Thandapilly, Sijo Joseph
    Raj, Pema
    Louis, Xavier Lieben
    Smoliga, James Michael
    Netticadan, Thomas
    TRIALS, 2016, 17
  • [9] Physical therapy for patellofemoral pain - A randomized, double-blinded, placebo-controlled trial
    Crossley, K
    Bennell, K
    Green, S
    Cowan, S
    McConnell, J
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2002, 30 (06): : 857 - 865
  • [10] Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial
    Singh, Jasvinder A.
    Mahowald, Maren L.
    Noorbaloochi, Siamak
    TRANSLATIONAL RESEARCH, 2009, 153 (05) : 205 - 216